Canandaigua National Bank & Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.8M | Buy |
+83,853
| New | +$9.81M | 0.91% | 23 |
|
|
2025
Q4 | $9.51M | Sell |
90,387
-1,556
| -2% | -$146K | 0.85% | 24 |
|
|
2025
Q3 | $7.72M | Sell |
91,943
-4,134
| -4% | -$340K | 0.68% | 29 |
|
|
2025
Q2 | $7.61M | Buy |
96,077
+8,282
| +9% | +$658K | 0.7% | 30 |
|
|
2025
Q1 | $7.88M | Buy |
87,795
+8,268
| +10% | +$772K | 0.79% | 27 |
|
|
2024
Q4 | $7.91M | Buy |
79,527
+467
| +0.6% | +$48.1K | 0.78% | 27 |
|
|
2024
Q3 | $8.98M | Sell |
79,060
-1,970
| -2% | -$234K | 0.85% | 24 |
|
|
2024
Q2 | $10M | Sell |
81,030
-625
| -0.8% | -$80.5K | 1.09% | 18 |
|
|
2024
Q1 | $10.8M | Sell |
81,655
-2,136
| -3% | -$263K | 1.59% | 11 |
|
|
2023
Q4 | $9.13M | Sell |
83,791
-2,497
| -3% | -$259K | 1.41% | 14 |
|
|
2023
Q3 | $8.88M | Sell |
86,288
-6,972
| -7% | -$751K | 1.44% | 14 |
|
|
2023
Q2 | $10.8M | Sell |
93,260
-9,672
| -9% | -$1.1M | 1.74% | 9 |
|
|
2023
Q1 | $11M | Buy |
+102,932
| New | +$11.1M | 1.84% | 7 |
|
|
2020
Q1 | $7.08M | Buy |
96,410
+2,377
| +3% | +$187K | 1.5% | 11 |
|
|
2019
Q4 | $8.16M | Sell |
94,033
-1,228
| -1% | -$101K | 1.38% | 14 |
|
|
2019
Q3 | $7.65M | Buy |
95,261
+2,453
| +3% | +$197K | 1.35% | 17 |
|
|
2019
Q2 | $7.43M | Buy |
92,808
+2,585
| +3% | +$198K | 1.37% | 17 |
|
|
2019
Q1 | $7.16M | Sell |
90,223
-2,539
| -3% | -$190K | 1.37% | 17 |
|
|
2018
Q4 | $6.76M | Sell |
92,762
-887
| -0.9% | -$62.6K | 1.43% | 16 |
|
|
2018
Q3 | $6.34M | Sell |
93,649
-445
| -0.5% | -$28.4K | 1.13% | 15 |
|
|
2018
Q2 | $5.45M | Buy |
94,094
+298
| +0.3% | +$16.8K | 1.05% | 19 |
|
|
2018
Q1 | $4.88M | Buy |
93,796
+1,880
| +2% | +$102K | 0.62% | 40 |
|
|
2017
Q4 | $4.93M | Buy |
91,916
+2,578
| +3% | +$143K | 0.89% | 30 |
|
|
2017
Q3 | $5.46M | Buy |
89,338
+11,080
| +14% | +$672K | 1.04% | 26 |
|
|
2017
Q2 | $4.79M | Sell |
78,258
-1,093
| -1% | -$66.5K | 0.98% | 28 |
|
|
2017
Q1 | $4.81M | Sell |
79,351
-3,302
| -4% | -$200K | 1.42% | 20 |
|
|
2016
Q4 | $4.64M | Buy |
82,653
+3,648
| +5% | +$213K | 1.39% | 18 |
|
|
2016
Q3 | $4.71M | Buy |
79,005
+3,656
| +5% | +$214K | 1.36% | 22 |
|
|
2016
Q2 | $4.14M | Buy |
75,349
+1,002
| +1% | +$53.3K | 1.18% | 26 |
|
|
2016
Q1 | $3.75M | Buy |
74,347
+2,995
| +4% | +$147K | 1.1% | 28 |
|
|
2015
Q4 | $3.6M | Buy |
71,352
+431
| +0.6% | +$21.7K | 1.1% | 27 |
|
|
2015
Q3 | $3.34M | Sell |
70,921
-1,103
| -2% | -$58.6K | 1.07% | 28 |
|
|
2015
Q2 | $3.91M | Buy |
72,024
+5,830
| +9% | +$327K | 1.15% | 25 |
|
|
2015
Q1 | $3.63M | Buy |
66,194
+6,649
| +11% | +$376K | 1.09% | 26 |
|
|
2014
Q4 | $3.23M | Sell |
59,545
-1,475
| -2% | -$82.2K | 1.03% | 28 |
|
|
2014
Q3 | $3.45M | Sell |
61,020
-1,357
| -2% | -$76.2K | 1.14% | 21 |
|
|
2014
Q2 | $3.44M | Sell |
62,377
-1,577
| -2% | -$86K | 1.14% | 22 |
|
|
2014
Q1 | $3.46M | Sell |
63,954
-686
| -1% | -$35.5K | 1.17% | 22 |
|
|
2013
Q4 | $3.09M | Sell |
64,640
-2,248
| -3% | -$103K | 1.09% | 26 |
|
|
2013
Q3 | $3.04M | Buy |
66,888
+1,501
| +2% | +$68.5K | 1.16% | 22 |
|
|
2013
Q2 | $2.9M | Buy |
+65,387
| New | +$2.92M | 1.13% | 25 |
|
Other funds holding MRK
ECSS
Canandaigua National Bank & Trust's MRK Position: Q2 2026 in Review
Canandaigua National Bank & Trust opened a new position in Merck (MRK) in Q2 2026: 83,853 shares worth $10.8M. The stake represents 0.91% of the portfolio and ranks #23 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in MRK as recently as Q4 2025.
Canandaigua National Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. The position peaked at $11M in Q1 2023. 2,016 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Canandaigua National Bank & Trust held 83,853 shares of Merck worth $10.8M as of Q2 2026.
- Merck was a new Canandaigua National Bank & Trust position in Q2 2026.
- Merck made up 0.91% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #23 holding.
- Canandaigua National Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
- Canandaigua National Bank & Trust's Merck position peaked at $11M in Q1 2023.
- 2,016 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.